US Patent Issued to ONELIFE on July 22 for "Composition comprising at least one enzyme and at least one microbicidal molecule for the prevention or treatment of post-implant infections" (Belgian Inventors)

ALEXANDRIA, Va., July 23 -- United States Patent no. 12,364,738, issued on July 22, was assigned to ONELIFE S.A. (Louvain-la-Neuve, Belgium).

"Composition comprising at least one enzyme and at least one microbicidal molecule for the prevention or treatment of post-implant infections" was invented by Wafi Siala (Woluwe St. Pierre, Belgium) and Thomas Vanzieleghem (Louvain-la-Neuve, Belgium).

According to the abstract* released by the U.S. Patent & Trademark Office: "The present invention relates to a composition comprising at least one enzyme and at least one microbicidal molecule as combination products, for simultaneous use, separated use or use staggered over time, for use in the preventative and/or curative treatment of infections at a...